Search Results - "BERNTSEN, Annika"
-
1
Identification of a new hTERT-derived HLA-A0201 restricted, naturally processed CTL epitope
Published in Cancer Immunology, Immunotherapy (01-11-2007)“…By the use of a neural network capable of performing quantitative predictions of peptides binding to HLA-A*0201 molecules, we identified a number of nonamer…”
Get full text
Journal Article -
2
Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
Published in Cytotherapy (Oxford, England) (01-10-2010)“…Abstract Background aims Dendritic cells are regarded as the most effective antigen presenting cells and coordinators of the immune response and therefore…”
Get full text
Journal Article -
3
Therapeutic Dendritic Cell Vaccination of Patients With Metastatic Renal Cell Carcinoma : A Clinical Phase 1/2 trial
Published in Journal of immunotherapy (1997) (01-10-2008)“…Therapeutic dendritic cell (DC) vaccination against cancer is a strategy aimed at activating the immune system to recognize and destroy tumor cells. In this…”
Get full text
Journal Article -
4
Comparison of α-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients
Published in Vaccine (02-06-2008)“…Abstract The current “gold standard” for generation of dendritic cell (DC) used in DC-based cancer vaccine studies is maturation of monocyte-derived DCs with…”
Get full text
Journal Article -
5
Therapeutic dendritic cell vaccination of patients with renal cell carcinoma
Published in European urology (01-07-2006)“…Dendritic cell (DC) vaccination against cancer is a new specific immunotherapeutic approach given with either therapeutic or adjuvant intent. We provide a…”
Get full text
Journal Article -
6
Comparison of [alpha]-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients
Published in Vaccine (02-06-2008)“…The current "gold standard" for generation of dendritic cell (DC) used in DC-based cancer vaccine studies is maturation of monocyte-derived DCs with tumor…”
Get full text
Journal Article -
7
Increase of Circulating CD4+CD25highFoxp3+ Regulatory T Cells in Patients With Metastatic Renal Cell Carcinoma During Treatment With Dendritic Cell Vaccination and Low-Dose Interleukin-2
Published in Journal of immunotherapy (1997) (01-05-2010)“…Regulatory T cells (Treg) play an important role in the maintenance of immune tolerance and may be one of the obstacles of successful tumor immunotherapy. In…”
Get full text
Journal Article -
8
Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans
Published in Clinical Immunology (01-11-2005)“…Elevated plasma IL-18 is present in several conditions sharing insulin-resistance as common trait, but the association with insulin-resistance per se is not…”
Get full text
Journal Article -
9
Elevated Plasma Interleukin-18 Is an Obesity-Independent Marker of Insulin-Resistance in Type 2 Diabetic and Non-Diabetic Humans
Published in Diabetes (New York, N.Y.) (01-06-2005)Get full text
Journal Article -
10
Dendrite cell-based cancer vaccines--clinical application
Published in Ugeskrift for læger (03-04-2006)“…Dendritic cell (DC)-based vaccination against cancer is a specific immunotherapy with a new therapeutic approach for patients with cancer. Preclinical and…”
Get more information
Journal Article -
11
Treatment of hospitalized patients in a medical department with acid-suppressing medication
Published in Ugeskrift for læger (13-09-2004)Get more information
Journal Article